CASE REPORT
Pathol. Oncol. Res.
Volume 31 - 2025 | doi: 10.3389/pore.2025.1612095
This article is part of the Special IssueCytometry in OncologyView all 3 articles
Case report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3
- 1Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- 2Department of Internal Medicine and Haematology, Faculty of Medicine, Semmelweis University, Budapest, Hungary
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Peripheral T-cell lymphomas (PTCLs) are a group of non-Hodgkin lymphomas originating from mature T-lymphocytes. Despite encompassing several well-defined entities, about 25% of the PTCLs do not fulfill the requirements of any of the subcategories. These diseases are classified as PTCL, not otherwise specified (PTCL, NOS), and often associated with poor prognosis. Hereby we present a case of a female patient, diagnosed with PTCL, NOS from her skin biopsy specimen. Besides histology and immunohistochemistry, flow cytometry was used for phenotyping and staging (peripheral blood, bone marrow). Pathologic T-cells were found in all the investigated tissues, with a very unusual CD45 negative and surface CD3 dim immunophenotype.
Keywords: Flow Cytometry, immunophenotype, peripheral T-cell lymphoma, differential diagnosis, PTCL, NOS
Received: 29 Jan 2025; Accepted: 06 May 2025.
Copyright: © 2025 Szalóki, Szepesi, Tárkányi, Márk, Tolnai-Kriston, Hunyadi, Mózes and Barna. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Gábor Barna, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.